---
title: "Jyong Biotech (MENS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MENS.US/norm.md"
symbol: "MENS.US"
name: "Jyong Biotech"
parent: "https://longbridge.com/en/quote/MENS.US.md"
datetime: "2026-03-08T06:55:40.967Z"
locales:
  - [en](https://longbridge.com/en/quote/MENS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MENS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MENS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MENS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MENS.US/norm.md)


# Jyong Biotech (MENS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0087 | -0.0087 | -0.0118 | -0.0118 | -0.0093 |
| ROE | 11.14% | 8.49% | 9.27% | 9.48% | 7.59% |
| Revenue | - | - | - | - | - |
| Net income | -626000.00 | -626000.00 | -846500.00 | -846500.00 | -663000.00 |
| Operating income | -408000.00 | -408000.00 | -552500.00 | -552500.00 | -475500.00 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 37.67M | 37.67M | 6.37M | 6.37M | 6.44M |
| Leverage | -1.68 | -1.68 | -0.1743 | -0.1743 | -0.1844 |
| BVPS | -0.3132 | -0.3132 | -0.5103 | -0.5103 | -0.4880 |
| Turnover | - | - | - | - | - |
| Cash & STI | 17.01M | 17.01M | 98000.00 | 98000.00 | 96000.00 |
| Inv & Rec | - | - | - | - | - |
| LT assets | 3.45M | 3.45M | 3.19M | 3.19M | 3.34M |
| Net debt | 18.19M | 18.19M | 18.04M | 18.04M | 17.27M |

## Cash Flow Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | - | -425500.00 | -425500.00 | -1.39M |
| Investing CF | - | - | - | - | - |
| Financing CF | - | - | 424000.00 | 424000.00 | 571000.00 |
| Free CF | - | - | -316313.00 | 53687.00 | -266188.00 |
| OCF coverage | - | - | -10.37% | -10.37% | -220.08% |
| Repaid & issued | - | - | 4.58M | 4.58M | 1.26M |
| CapEx | - | - | - | - | - |